drugset / Trial / NCT00933686

Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome

NCT00933686

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of recombinant human growth hormone (r-hGH) treatment in severe fibromyalgia subjects with growth axis dysfunction.

Timeline

Start
2007-12
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic 0.006 mg/kg Subcutaneous

Indications